August 3rd 2023
Statistically significant positive immune responses were observed in both vaccine-naive adults and those previously vaccinated, including for the vaccine's 8 unique serotypes.
May 8th 2023
New CDC recommendations for pneumococcal vaccination for persons aged 19 to 64 years could require some extra thought. This 4-question quiz tests your knowledge.
December 1st 2022
Respiratory syncytial virus is an age-old winter foe that could affect many of your patients this year. Take a minute and scan these facts for a refresher.
July 1st 2022
In persons with COPD, seasonal influenza and PPSV23 vaccines, separately or together, reduced the risk for COPD- and pneumonia-related hospitalizations.
June 22nd 2022
The 21-valent pneumococcal conjugate vaccine targets 85% of invasive pneumococcal disease in adults aged ≥65 years; 8 serotypes are exclusive to this vaccine, says Merck.
CDC 2023 Immunization Updates for 5 Vaccine-Preventable Illnesses
See highlights of CDC 2023 immunization updates for: pneumococcal disease; measles, mumps, and rubella; hepatitis B; polio; and monkeypox.
Changes to the ACIP 2023 Adult Immunization Schedule
Get a quick topline look at specific revisions and additions included in the ACIP's recommendations for routine immunization of those aged ≥19 years in the US.
Diphtheria First Choice for Pediatric Immunization: A Short Quiz
How much do you know about diphtheria and the vaccine? Answer these 2 questions to find out.
4 Pediatric Pneumococcal Vaccine Conundrums
SAMPLE: A 7-year-old child newly immigrated to the US has not received any previous pneumococcal vaccines. What does the CDC recommend for this child?
New Choices in Pneumococcal Vaccines: A 4-question Quiz
How much do you know about the latest adult pneumococcal vaccine recommendations from the ACIP? Try your hand at these 4 questions to find out.
Adult Vaccination Against Preventable Diseases Now Urgent, says NAIIS
Low rates of routine adult vaccination, reduced further during the 2020-21 pandemic months, threaten a surge in these conditions as the US reopens, says the National Adult and Influenza Immunization Summit.
ACP: Ensure Adult Routine Vaccinations are Up to Date as Flu and COVID Meet Again
The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.
Study Finds Persistent Racial/Ethnic, Socioeconomic Disparities in Adult Vaccination Coverage 2010 - 2019
Rates of routine ACIP-recommended vaccination have been persistently and significantly lower among racial and ethnic minorities over the past decade, according to new research.
6 New Drugs Approved for Primary Care: Q2 2021
From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.
FDA-approved: Pneumococcal 20-Valent Conjugate Vaccine for Adults
The vaccine is indicated for prevention of invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.
ACP Guidance on Antibiotic Use: 4 Conditions Ideal for Short-course Treatment
Longer antibiotic treatment courses can often be safely and effectively shortened, according to the ACP guidance; 4 common conditions serve as examples.
Routine Adult Vaccination Rates Still Low: Slow Post-lockdown Rebound
Routine adult vaccination rates have yet to reach pre-pandemic levels, according to a report in MMWR this week. Which vaccines are most affected and which groups are lagging?
ACIP 2021 Adult Immunization Schedule Changes: A Quick Take
Review changes to the CDC Advisory Committee on Immunization Practices' 2021 recommended vaccination schedule for adults with this short slide-show review.
Influenza, Pneumococcal Disease, and COVID-19: What do Americans Think?
A new survey from the National Foundation for Infectious Diseases found key insights into what Americans believe about flu, pneumococcal disease, and COVID-19.
USPSTF (Still) Recommends Against Screening for COPD
Once again, the USPSTF finds no net benefit to screening asymptomatic persons for COPD. Draft recommendation is available for comment.
Corticosteroids Improved Outcomes, Recovery from Community Acquired Pneumonia
Reductions in mortality, need for life support, hospital stays, and other measures should win this drug class serious consideration, study authors say.
Risk Factors Identified for 30-day Mortality in Patients with Pneumonia
Targeting these risk factors with adjunctive therapy may help improve outcomes, say authors of a new study.
Viruses Found Responsible for Burden of Hospitalizations from CAP
A new CDC study also found that older adults are more likely to be hospitalized for a severe respiratory virus than those aged 18 to 49 years.
Pneumonia Hits Older Adults Hardest
Infections with pneumonia send a substantial number of older adults to the hospital, much more than younger adults. Researchers are calling for new rapid diagnostic tests.
PPI Use Upped Risk for Community-Acquired Pneumonia
Proposed mechanisms for the association include PPI-induced acute pH dysregulation and alteration of the gut microbiome.
Pneumonia Significantly Increased Costs of ICU Stays
The price tag for an ICU stay was more than 5 times higher for pneumonia patients. Can we find an ounce of prevention?
Lung Disease Often Missed in Long-term Smokers
Undiagnosed lung disease in smokers, the impact of guidelines for community-acquired pneumonia in children, and climate change and asthma attacks make headlines in the respiratory news.
Inpatient Physical Therapy After CAP Reduced Readmissions
Thirty minutes/day of hospital-based physical therapy reduced 30-day readmission, an important Medicare hospital performance metric.
Biomarker Added to PSI Helps Risk-Stratify Patients With CAP
The combined measures may help reduce hospitalizations by reclassifying CAP patients at low risk for adverse events.
Breathe It All In: Respiratory Disease Roundup
Respiratory disease is the main reason why patients visit primary care practices. This brief summary highlights the latest in research and patient care.
Respiratory: The Top Reason Patients Come to Primary Care
This slideshow highlights facts and figures about the number 1 diagnostic category in primary care.
3 Very New Findings About Pneumonia
Three studies culled from the very recent literature offer insights into prevention and treatment of pneumonia in adults. Highlights in this slide show.
PCV13: Effective Against First-Episode CAP in Older Adults
The 13-valent pneumococcal conjugate vaccine reduced nearly by half vaccine-type community acquired pneumonia in adults aged 65 years and older.
Hospitalization for Pneumonia Linked to Risk for CVD
Risk of MI, stroke, and fatal coronary heart disease remained elevated among some patients hospitalized for pneumonia up to 10 years after the index event.
Shortness of Breath Sends Patients to the ED
Several related health concerns-including asthma, pericarditis, and pneumonia-are treatable within the primary care office.
2 Clarke Drive Cranbury, NJ 08512